214 related articles for article (PubMed ID: 24979706)
1. Assessing additional benefit in noninferiority trials.
Kieser M; Stucke K
Biom J; 2016 Jan; 58(1):154-69. PubMed ID: 24979706
[TBL] [Abstract][Full Text] [Related]
2. Superiority inferences on individual endpoints following noninferiority testing in clinical trials.
Logan BR; Tamhane AC
Biom J; 2008 Oct; 50(5):693-703. PubMed ID: 18932132
[TBL] [Abstract][Full Text] [Related]
3. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
Hida E; Tango T
J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
[TBL] [Abstract][Full Text] [Related]
4. Power and sample size for clinical trials when efficacy is required in multiple endpoints: application to an Alzheimer's treatment trial.
Xiong C; Yu K; Gao F; Yan Y; Zhang Z
Clin Trials; 2005; 2(5):387-93. PubMed ID: 16317808
[TBL] [Abstract][Full Text] [Related]
5. Bayesian design and analysis of composite endpoints in clinical trials with multiple dependent binary outcomes.
Zaslavsky BG
Pharm Stat; 2013; 12(4):207-12. PubMed ID: 23625660
[TBL] [Abstract][Full Text] [Related]
6. Sample size determination and re-estimation for matched pair designs with multiple binary endpoints.
Xu J; Yu M
Biom J; 2013 May; 55(3):430-43. PubMed ID: 23553605
[TBL] [Abstract][Full Text] [Related]
7. Challenge of multiple co-primary endpoints: a new approach.
Chuang-Stein C; Stryszak P; Dmitrienko A; Offen W
Stat Med; 2007 Mar; 26(6):1181-92. PubMed ID: 16927251
[TBL] [Abstract][Full Text] [Related]
8. The issue of multiplicity in noninferiority studies.
Ke C; Ding B; Jiang Q; Snapinn SM
Clin Trials; 2012 Dec; 9(6):730-5. PubMed ID: 22879575
[TBL] [Abstract][Full Text] [Related]
9. Multiplicity adjustment for composite binary endpoints.
Rauch G; Kieser M
Methods Inf Med; 2012; 51(4):309-17. PubMed ID: 22525969
[TBL] [Abstract][Full Text] [Related]
10. Statistical analysis of noninferiority trials with a rate ratio in small-sample matched-pair designs.
Chan IS; Tang NS; Tang ML; Chan PS
Biometrics; 2003 Dec; 59(4):1170-7. PubMed ID: 14969498
[TBL] [Abstract][Full Text] [Related]
11. Sample size calculations for noninferiority trials with Poisson distributed count data.
Stucke K; Kieser M
Biom J; 2013 Mar; 55(2):203-16. PubMed ID: 23401289
[TBL] [Abstract][Full Text] [Related]
12. Design and analysis of three-arm trials with negative binomially distributed endpoints.
Mütze T; Munk A; Friede T
Stat Med; 2016 Feb; 35(4):505-21. PubMed ID: 26388314
[TBL] [Abstract][Full Text] [Related]
13. Multiple-arm superiority and non-inferiority designs with various endpoints.
Chang M
Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
[TBL] [Abstract][Full Text] [Related]
14. Sequential parallel comparison design for "gold standard" noninferiority trials with a prespecified margin.
Homma G; Daimon T
Biom J; 2019 Nov; 61(6):1493-1506. PubMed ID: 31456230
[TBL] [Abstract][Full Text] [Related]
15. Mixed noninferiority margin and statistical tests in active controlled trials.
Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
[TBL] [Abstract][Full Text] [Related]
16. Bayesian hypothesis testing in two-arm trials with dichotomous outcomes.
Zaslavsky BG
Biometrics; 2013 Mar; 69(1):157-63. PubMed ID: 23002906
[TBL] [Abstract][Full Text] [Related]
17. Adaptive designs for noninferiority trials.
Gao P; Liu L; Mehta C
Biom J; 2013 May; 55(3):310-21. PubMed ID: 23494872
[TBL] [Abstract][Full Text] [Related]
18. Test Statistics and Confidence Intervals to Establish Noninferiority between Treatments with Ordinal Categorical Data.
Zhang F; Miyaoka E; Huang F; Tanaka Y
J Biopharm Stat; 2015; 25(5):921-38. PubMed ID: 24919157
[TBL] [Abstract][Full Text] [Related]
19. Type I error and power in noninferiority/equivalence trials with correlated multiple endpoints: an example from vaccine development trials.
Kong L; Kohberger RC; Koch GG
J Biopharm Stat; 2004 Nov; 14(4):893-907. PubMed ID: 15587971
[TBL] [Abstract][Full Text] [Related]
20. Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance.
Li H; Wang J; Luo X; Grechko J; Jennison C
Biom J; 2018 Sep; 60(5):893-902. PubMed ID: 29876964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
